Showing results (3821-3830 of 6,740) with videos related to

Sort By:
Pageof 674
Oncotargets and Therapy|March 29, 2018
Peripheral inflammation/immune indicators of chemosensitivity and prognosis in breast cancer patients treated with neoadjuvant chemotherapyYi Qian, Jing Tao, Xiuqing Li, et al.
Oncotargets and Therapy|March 29, 2018
Measurement of serum PODXL concentration for detection of pancreatic cancerKeisuke Taniuchi, Makiko Tsuboi, Masahiko Sakaguchi, et al.
Oncotargets and Therapy|March 29, 2018
Midazolam activates caspase, MAPKs and endoplasmic reticulum stress pathways, and inhibits cell cycle and Akt pathway, to induce apoptosis in TM3 mouse Leydig progenitor cellsFu-Chi Kang, Shu-Chun Wang, Ming-Min Chang, et al.
Oncotargets and Therapy|March 30, 2018
miR-622 suppresses tumor formation by directly targeting VEGFA in papillary thyroid carcinomaRenjie Wang, Qingjie Ma, Linlin Ji, et al.
Oncotargets and Therapy|March 30, 2018
Hsp90 inhibitor NMS-E973 exerts the anticancer effect against glioblastoma via induction of PUMA-mediated apoptosisLibo Sun, Shoujun Yang, Guonan Chi, et al.
Oncotargets and Therapy|March 15, 2018
rs11614913 polymorphism in miRNA-196a2 and cancer risk: an updated meta-analysisYuhan Liu, Anbang He, Baoer Liu, et al.
Oncotargets and Therapy|March 15, 2018
Hepatitis C virus core impacts expression of miR122 and miR204 involved in carcinogenic progression via regulation of TGFBRAP1 and HOTTIP expressionXiaoying Wang, Jiefu Peng, Jing Wang, et al.
Oncotargets and Therapy|February 9, 2018
Quantification of heart, pericardium, and left ventricular myocardium movements during the cardiac cycle for thoracic tumor radiotherapyYing Tong, Yong Yin, Jie Lu, et al.
Oncotargets and Therapy|February 9, 2018
A non-synonymous polymorphism in NBS1 is associated with progression from chronic hepatitis B virus infection to hepatocellular carcinoma in a Chinese populationYa'nan Zhen, Ruixue Xiao, Xing Chen, et al.
Oncotargets and Therapy|February 9, 2018
miR-106b-5p promotes stem cell-like properties of hepatocellular carcinoma cells by targeting PTEN via PI3K/Akt pathwayDong-Min Shi, Xin-Yu Bian, Cheng-Dong Qin, et al.
Pageof 674